David Berube attended the Sustainable Nanotechnology Organization (SNO) (http://www.susnano.org/) annual meeting in Orlando, Florida on October 10-12, 2016. He delivered a paper as the first speaker of the first panel on November 10, 2016, and spoke about “Reframing Nanotechnology” where he made a case for marketing science in the upcoming decade to meet the contextual interests of both the new administration and the public at large.
We are excited to announce that RTNN’s Dr. David Berube will serve as a member on the Risk Communication Advisory Committee for the Food and Drug Administration (FDA) beginning this October and spanning into the next administration. As a committee member, Dr. Berube will advise the FDA Commissioner on strategies to effectively communicate the risks and benefits of FDA-regulated products to the public. The committee is also tasked with reviewing and evaluating relevant research and facilitating the implementation of public communication programs.